SQUAWK/NEWS
Menu
Live News EQUITY L impact

Galectin Therapeutics Files SEC Form

Galectin Therapeutics submits filing to SEC, details not specified

GALT

Filed: 2026-05-28 AccNo: 0001133416-26-000055 Size: 9 KB